ICON Announces Appointment of New Chief Financial Officer
August 14 2024 - 4:15PM
Business Wire
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence
and clinical research organisation, today announced the appointment
of Nigel Clerkin as its new Chief Financial Officer (CFO).
Nigel brings extensive experience and capability to the role of
CFO. He commenced his career with KPMG, before joining Elan
Corporation where he held a number of roles of increasing
responsibility over a fifteen-year career, culminating in the role
of group CFO in 2011, which he held until 2014. Nigel then moved to
be CFO at ConvaTec, a global medical and technologies company,
before becoming UDG Healthcare’s CFO in 2018. During his tenure
with UDG, he led substantial change and improvement programmes and
oversaw strong financial growth across multiple business lines.
Most recently, Nigel was CFO at LetsGetChecked, a global provider
of at-home healthcare services.
Nigel has a long tenure and a strong track record of success as
CFO in a number of large organisations in the life sciences and
healthcare services industry. He has successfully led and supported
the financial growth of a number of organisations and has a strong
background as a CFO of a public company with significant experience
in M&A as well as financial processes and systems
enhancement.
Nigel holds a Bachelor of Science (Accounting) degree and a
Master of Accounting degree from Queen’s University Belfast and is
also a qualified chartered accountant and a fellow of Chartered
Accountants Ireland.
Nigel will be based in ICON’s Dublin office and will join ICON
early in quarter four this year.
“I am pleased to announce Nigel’s appointment as ICON’s next
CFO,” said Steve Cutler, ICON’s CEO. “His vast experience as a CFO
across a number of life science and healthcare service
organisations will bring valuable experience, insights and new
perspectives to the role. I look forward to working with Nigel in
the years ahead as ICON continues to grow and become the healthcare
intelligence partner of choice for all of our customers. Finally, I
would also like to thank our outgoing CFO, Brendan Brennan, for his
significant contribution to ICON over the past 18 years and wish
him further success in the future.”
“It is a privilege to have been selected to be ICON’s next CFO,”
said Nigel Clerkin. “ICON is a company I have long admired and
respected and I have been continuously impressed with the company’s
performance and continuing growth as a market leader within the CRO
industry. I look forward to working with the ICON Executive team
and working closely with the strong talent across the organisation
particularly within the finance team, to continue ICON’s growth and
success into the future.”
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical
research organisation. From molecule to medicine, we advance
clinical research providing outsourced services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. We develop new innovations, drive emerging therapies
forward and improve patient lives. With headquarters in Dublin,
Ireland, ICON employed approximately 41,100 employees in 97
locations in 55 countries as at June 30, 2024. For further
information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements,
including statements about our financial guidance. These statements
are based on management's current expectations and information
currently available, including current economic and industry
conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
other economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are
available on the SEC's website at http://www.sec.gov.
ICON/ICLR-F
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240814475660/en/
Kate Haven Vice President Investor Relations +1 888 381 7923
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Jul 2024 to Aug 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Aug 2023 to Aug 2024